Ophthalmology, Retina Specialist · Santa Barbara, CA
NPI
1316980014
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
525 E Micheltorena St Ste A
Santa Barbara, CA, 93103
Phone (805) 963-1648
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.6M
67,250 services
Medicare patients, 2024
2,137
Average age 77
Drug cost, 2024
$131K
1,369 prescriptions
Company payments, 2025
$30K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen S Couvillion was code J2777 (injection, faricimab-svoa, 0.1 mg), 24,420 times for 80 patients. In total Stephen S Couvillion billed 67,250 services in 67 codes, and Medicare paid $7.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 24,420 | 80 | $27.49 | $671K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 8,251 | 370 | $181.44 | $1.5M |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 6,140 | 65 | $86.55 | $531K |
| 92134 Computerized Ophthalmic Imaging | Office | 5,799 | 1,932 | $29.48 | $171K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 5,288 | 149 | $264.29 | $1.4M |
| 67028 Intravitreal Injection | Office | 3,870 | 848 | $109.23 | $423K |
| Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2,030 | 167 | $133.94 | $272K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,880 | 219 | $653.04 | $1.2M |
| 92014 Ophthalmological E&M | Office | 1,820 | 1,355 | $95.53 | $174K |
| 92012 Ophthalmological E&M | Office | 1,585 | 798 | $72.32 | $115K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 1,046 | 61 | $124.90 | $131K |
| 92250 Angiography | Office | 712 | 501 | $25.81 | $18K |
| 92202 Ophthalmological E&M | Office | 607 | 539 | $11.67 | $7,086 |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 357 | 32 | $161.11 | $58K |
| J3490 Unclassified drugs | Office | 250 | 117 | $1,969.33 | $492K |
By year: 2022 $5.8M for 37,339 services; 2023 $6.5M for 63,873 services; 2024 $7.6M for 67,250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen S Couvillion prescribed most often to Medicare patients was Prednisolone Acetate, with 242 prescriptions and refills. In total Stephen S Couvillion wrote 1,369 Medicare prescriptions that cost $131K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 242 | 360 | 132 | $12K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 137 | 140 | 92 | $1,325 |
| Ketorolac Tromethamine Generic | 136 | 190 | 66 | $2,487 |
| Moxifloxacin Moxifloxacin Hcl | 115 | 118 | 83 | $2,701 |
| Atropine Sulfate Generic | 111 | 160 | 83 | $5,538 |
| Latanoprost Generic | 78 | 137 | 22 | $676 |
| Erythromycin Erythromycin Base | 72 | 72 | 56 | $786 |
| Timolol Maleate Generic | 61 | 152 | 24 | $307 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 57 | 124 | 30 | $879 |
| Brimonidine Tartrate Generic | 54 | 100 | 20 | $4,389 |
| Prolensa Bromfenac Sodium | 31 | 34 | 13 | $10K |
| Lumigan Bimatoprost | 24 | 42 | Under 11 | $9,574 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 21 | 47 | Under 11 | $3,381 |
| Bromfenac Sodium Generic | 20 | 35 | Under 11 | $5,217 |
| Alphagan P Brimonidine Tartrate | 18 | 32 | 12 | $6,324 |
Brand drugs: 472 claims; generic drugs: 897 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen S Couvillion $30K ($30K in general payments such as food, travel and fees) from 11 companies. The largest payer was Genentech USA, Inc. with $28K.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 24 | $28K |
| Alcon Vision LLC ALC | 4 | $584 |
| Apellis Pharmaceuticals, Inc. APLS | 8 | $343 |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $245 |
| Abbvie Inc. ABBV | 7 | $177 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $150 |
| Neurotech Pharmaceuticals, Inc. | 1 | $101 |
| Harrow Eye, LLC | 5 | $93.52 |
| Astellas Pharma US Inc 4503.T | 2 | $42.66 |
| Biogen, Inc. BIIB | 1 | $23.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.